Genmab A/S (GMAB)
43.79
+3.79
(+9.48%)
USD |
NASDAQ |
Oct 23, 16:00
44.82
+1.03
(+2.35%)
After-Hours: 05:06
Genmab Price to Book Value : 4.389 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.389 |
| October 22, 2026 | 4.009 |
| October 21, 2026 | 3.966 |
| October 20, 2026 | 3.916 |
| October 19, 2026 | 3.859 |
| October 16, 2026 | 3.708 |
| October 15, 2026 | 3.790 |
| October 14, 2026 | 3.697 |
| October 13, 2026 | 3.665 |
| October 12, 2026 | 3.745 |
| October 09, 2026 | 3.715 |
| October 08, 2026 | 3.613 |
| October 07, 2026 | 3.673 |
| October 06, 2026 | 3.788 |
| October 05, 2026 | 3.856 |
| October 02, 2026 | 3.483 |
| October 01, 2026 | 3.463 |
| September 30, 2026 | 3.575 |
| September 29, 2026 | 3.565 |
| September 28, 2026 | 3.544 |
| September 25, 2026 | 3.540 |
| September 24, 2026 | 3.491 |
| September 23, 2026 | 3.483 |
| September 22, 2026 | 3.530 |
| September 21, 2026 | 3.477 |
| Date | Value |
|---|---|
| September 18, 2026 | 3.482 |
| September 17, 2026 | 3.461 |
| September 16, 2026 | 3.448 |
| September 15, 2026 | 3.423 |
| September 14, 2026 | 3.272 |
| September 11, 2026 | 3.254 |
| September 10, 2026 | 3.230 |
| September 09, 2026 | 3.311 |
| September 08, 2026 | 3.360 |
| September 04, 2026 | 3.368 |
| September 03, 2026 | 3.449 |
| September 02, 2026 | 3.429 |
| September 01, 2026 | 3.336 |
| August 31, 2026 | 3.323 |
| August 28, 2026 | 3.330 |
| August 27, 2026 | 3.418 |
| August 26, 2026 | 3.382 |
| August 25, 2026 | 3.444 |
| August 24, 2026 | 3.309 |
| August 21, 2026 | 3.352 |
| August 20, 2026 | 3.348 |
| August 19, 2026 | 3.419 |
| August 18, 2026 | 3.303 |
| August 17, 2026 | 3.291 |
| August 14, 2026 | 3.201 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| Ascendis Pharma A/S | 9.732 |
| Zealand Pharma A/S | 0.8591 |
| Bavarian Nordic A/S | 1.384 |
| Evaxion AS | 3.290 |
Price to Book Value Related Metrics
| PE Ratio | 34.68 |
| PS Ratio | 6.761 |
| Price to Free Cash Flow | 32.11 |
| Price | 43.79 |
| Earnings Yield | 2.88% |
| Market Cap | 26.14B |
| Operating PE Ratio | 20.95 |
| Normalized PE Ratio | 28.42 |